Document is current
Any future updates will be listed below
-
Authors
de Oliveira Rosa, Virginia https://orcid.org/0000-0003-0927-8976
Rosa Franco, Alexandre
Abrahão Salum Júnior, Giovanni
Moreira-Maia, Carlos Renato
Wagner, Flávia
Simioni, André
de Fraga Bassotto, Caroline
R. Moritz, Guilherme
Schaffer Aguzzoli, Cristiano
Buchweitz, Augusto
Schmitz, Marcelo
Rubia, Katya
Paim Rohde, Luis Augusto
-
Funding
Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (0433-2551/14-0)
Attention-Deficit/Hyperactivity Disorder Outpatient Program
Conselho Nacional de Desenvolvimento Científico e Tecnológico (140672/2014-1)
- License Information
-
More Information
Article History
First Online: 19 June 2019
Compliance with ethical standards
:
: Luis A. Rohde has received honoraria, has been on the speakers’ bureau/advisory board and/or has acted as a consultant for Eli-Lilly, Medice, Novartis and Shire in the last three years. He receives authorship royalties from Oxford Press and ArtMed. He also received travel awards for taking part of the 2015 WFADHD and 2016 AACAP meetings from Shire. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Janssen-Cilag, Novartis, and Shire. Dr. Carlos Renato Moreira-Maia has received financial research support from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq); development of educational materials for Libbs, Novartis and Pfizer; has received travel and accommodation support for a speaker training and participated in the development of a cell phone applicative for Shire; has received travel, accommodation and registration support to the fourth and fifth World Congress on ADHD from the World Federation of ADHD. Other authors do not have conflicts to declare. Dr. Schmitz has received financial support from Shire Laboratories to participate in international meetings. Katya Rubia has received grants for other projects from Shire and Lilly and speaker’s honoraria from Shire, Lilly, Medice and Novartis.
: The study was approved by the Ethics and Research Committee of the Hospital de Clínicas de Porto Alegre (HCPA) – (CAAE 25048913.8.0000.5327). All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in this study.
